T315I-mutated myeloid sarcoma

We report the first case of a patient with T315I mutated myeloid sarcoma that occurred after complete cytogenetic response with dasatinib of a chronic phase CML. The patient was successfully treated with induction chemotherapy and ponatinib.
Source: Leukemia Research Reports - Category: Hematology Source Type: research